Mark J. Ratain to Arylsulfotransferase
This is a "connection" page, showing publications Mark J. Ratain has written about Arylsulfotransferase.
Connection Strength
0.028
-
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenet Genomics. 2013 Jul; 23(7):374-81.
Score: 0.028